TCR-engineered T cells HRYZ-T101
Term · Oncology and biomedicine · MLC-T-ONC-017001
A preparation of genetically engineered T lymphocytes expressing a T-cell receptor (TCR) targeting a specific tumor-associated antigen (TAA) of the human papillomavirus (HPV) type 18 (HPV-18), with potential antineoplastic activity. Upon administration, HPV-18 expressing TCR T cells target and bind to tumor cells expressing the HPV-18 TAA leading to selective cytotoxicity in HPV-18 TAA-expressing tumor cells. HPV18 TAAs are overexpressed in a variety of tumor cell types.
| Identifier | MLC-T-ONC-017001 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | TCR-T cells HRYZ-T101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017001",
"term": "TCR-engineered T cells HRYZ-T101",
"field": "Oncology and biomedicine",
"definition": "A preparation of genetically engineered T lymphocytes expressing a T-cell receptor (TCR) targeting a specific tumor-associated antigen (TAA) of the human papillomavirus (HPV) type 18 (HPV-18), with potential antineoplastic activity. Upon administration, HPV-18 expressing TCR T cells target and bind to tumor cells expressing the HPV-18 TAA leading to selective cytotoxicity in HPV-18 TAA-expressing tumor cells. HPV18 TAAs are overexpressed in a variety of tumor cell types.",
"synonyms": [
"TCR-T cells HRYZ-T101"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tcr-engineered-t-cells-hryz-t101/"
}
Record 16,050 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.